The Saudi Minister of Health and Chairman of the Board of Directors of the Saudi Food and Drug Authority (SFDA), H.E. Fahd bin Abdurrahman Al-Jalajel, launched a licensing initiative today for medical software in digital health. This initiative facilitates the use of software for diagnosis, treatment, and medical decision-making. The launch ceremony, held during the Global Health Exhibition 2024 in Riyadh from October 21 to 23, was attended by the CEO of the SFDA, H.E. Dr. Hisham S. Aljadhey. 

The SFDA’s initiative aims to support investment and industry in the field of medical device and supply software. It paves the way for innovators, research centers, and investors to introduce modern technologies in the Kingdom of Saudi Arabia without the need to establish physical factories. Additionally, it contributes to the advancement of digital diagnosis and treatment mechanisms.

Medical software has become an indispensable tool for diagnosis, treatment, and decision-making in healthcare. The SFDA’s new licensing initiative demonstrates the Kingdom's commitment to keeping pace with technological advancements while providing services that meet the highest quality standards.